OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Jan 8, 2016
Insider Transaction Report
Form 4
JACOBY PHILIP R JR
Vice President of Finance
Transactions
- Disposition to Issuer
Incentive Stock Option (right to buy)
2016-01-08$5.08/sh−5,000$25,400→ 54,181 totalExercise: $5.08From: 2016-03-23Exp: 2016-10-21→ Common Stock (5,000 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2016-01-08$7.73/sh−10,000$77,300→ 44,181 totalExercise: $7.73From: 2016-02-12Exp: 2016-10-21→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Unvested incentive stock options that were forfeited concurrent with the Reporting Person's retirement from employment with the Registrant, consistent with the provisions of the Amended and Restated 2006 Omnibus Plan. The Reporting Person's stock options that were vested on the date that he was determined to be medically disabled will remain exercisable for twelve months from the date of disability.